Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Year: 2012
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G3680653400
OpenAlex ID: W2145803146
